(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Is Iran using cryptocurrencies to circumvent sanctions? - 2How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
- 3Top Breakfast Food: What's Your Morning Enjoyment?
- 4My Excursion to Monetary Autonomy: Awesome ways to save cash
- 5Top 15 Online Entertainment Stages for Individual Marking
- An eye for an eye: People agree about the values of body parts across cultures and eras
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Extraordinary Snowboarding Objections All over the Planet
- Figure out how to Guarantee Your Dental Embeds Endure forever
- This Is Canada's Only Province Without Any Bears
- Grasping Various Kinds of Local misdemeanors
- Don't fall for it: These common tourist scams in Rome are easy to avoid if you know what you're looking for
- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
- Find the Advantages of Careful Eating: Developing a Sound Connection with Food
